Evidence map›Paper›PMID 40698579›Full record

ArticleCancer medicine2025

Evaluating Sleep in Pediatric Cancer: A Scoping Review of Assessment Tools for Quality and Care.

Elena Rostagno, Veronica Rivi, Pierfrancesco Sarti, Pietro Guastella, Dorella Scarponi, Johanna Maria Catharina Blom

Abstract readScoping Review
In one paragraph

Article in Cancer medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elena RostagnoPediatric Hematology and Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Veronica RiviDepartment of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.ORCID https://orcid.org/0000-0002-8413-4510
Pierfrancesco SartiDepartment of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Pietro GuastellaIRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.
Dorella ScarponiIRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.
Johanna Maria Catharina BlomDepartment of Biomedical, Metabolic, and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPediatric cancer patients experience unique and multifaceted sleep disturbances due to the disease, treatment regimens, and the hospital environment. These disruptions can detrimentally impact neurocognitive functioning, emotional well-being, and overall quality of life, making accurate sleep assessment critical yet challenging in this population.

objectiveTo examine and evaluate the current tools used to assess sleep quality in pediatric oncology patients, with a focus on their reliability, feasibility, and relevance to clinical and research settings.

methodsA scoping review methodology was employed to identify and synthesize studies using various sleep assessment tools in pediatric cancer populations. Tools reviewed included actigraphy, sleep diaries, validated sleep scales, and polysomnography. Studies were analyzed for general reliability, feasibility in clinical and research contexts, and applicability to pediatric oncology-specific concerns.

resultsThe review found that while actigraphy and sleep diaries are frequently used because of their noninvasive nature and relative ease of implementation, limitations exist in terms of consistency and interpretability. Sleep scales varied in their psychometric properties and relevance across age groups and treatment phases. Polysomnography, though considered the gold standard, was less feasible in routine clinical settings because of its complexity and cost. Across tools, variability was observed in the alignment between measured parameters and clinically relevant sleep issues in pediatric cancer patients.

conclusionA wide range of tools exists for assessing sleep in pediatric oncology, each with distinct strengths and limitations. Selection of the most appropriate tool should consider the specific sleep concern, patient age, clinical context, and resource availability. This review provides a framework for clinicians and researchers to make informed choices, encouraging thoughtful integration of sleep assessments into both practice and study design.

Indexed as

NeoplasmsSleepSleep QualitySleep Wake DisordersActigraphyChildHumansPolysomnographyPsychometricsQuality of Health CareQuality of LifeReproducibility of Resultsactigraphypediatric oncologysleep assessmentsleep disorderssleep qualitywearables

Identifiers

PMID40698579
PMCPMC12284734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.